Mary P. McGowan
2016
In 2016, Mary P. McGowan earned a total compensation of $690.1K as Chief Medical Officer at Esperion Therapeutics, a 92% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $75,000 |
|---|---|
| Option Awards | $208,734 |
| Salary | $395,000 |
| Other | $11,356 |
| Total | $690,090 |
McGowan received $395K in salary, accounting for 57% of the total pay in 2016.
McGowan also received $75K in non-equity incentive plan, $208.7K in option awards and $11.4K in other compensation.
Rankings
In 2016, Mary P. McGowan's compensation ranked 9,948th out of 14,075 executives tracked by ExecPay. In other words, McGowan earned more than 29.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,948 out of 14,075 | 29th |
Division Manufacturing | 3,842 out of 5,488 | 30th |
Major group Chemicals And Allied Products | 1,348 out of 1,900 | 29th |
Industry group Drugs | 1,076 out of 1,543 | 30th |
Industry Pharmaceutical Preparations | 843 out of 1,173 | 28th |
Source: SEC filing on March 6, 2017.
McGowan's colleagues
We found four more compensation records of executives who worked with Mary P. McGowan at Esperion Therapeutics in 2016.